DR. EDWARD L. ERB, D.O.

KERRVILLE, TX

Research Active
Surgery - Vascular Surgery NPI registered 21+ years 14 publications 1969 – 2024 NPI: 1053313163
RatsCells, CulturedModels, MolecularInflammationAdministration, OralStructure-Activity RelationshipProtein BindingEnzyme InhibitorsProtein Kinase InhibitorsBinding SitesModels, ChemicalDrug DesignAllosteric SiteAmidesp38 Mitogen-Activated Protein Kinases

Practice Location

575 HILL COUNTRY DR
KERRVILLE, TX 78028

Phone: (830) 258-7762

What does EDWARD ERB research?

Dr. Erb's research covers several key areas related to patient care and recovery after surgery. He examines how guidelines influence opioid prescriptions for children recovering from procedures like knee surgery and how prior emergency department visits can predict recovery challenges in patients undergoing total knee replacements. Additionally, he investigates the effectiveness of various surgical repair techniques, particularly for Achilles tendon injuries. Beyond surgery, he has worked on developing new drugs that target inflammation, which can help treat conditions like rheumatoid arthritis and improve the quality of life for affected individuals.

Key findings

  • In a study involving 86 pediatric patients, opioid prescriptions decreased by more than 20 units for each year of age after new guidelines were implemented, although follow-up prescriptions increased.
  • Data from 611 patients indicated that those with preoperative emergency department visits were more likely to return within 90 days after total knee arthroplasty, particularly if they had diabetes.
  • Tape repairs of torn Achilles tendons showed an average strength of 290.4 Newtons, significantly higher than 231.7 Newtons for traditional sutures, which could lead to better recovery outcomes.
  • A new drug called KR-003048 reduced joint swelling in animal models of arthritis by effectively blocking p38 MAP kinase at doses of 10 and 30 mg/kg.
  • Improvements in p38 MAP kinase inhibitors have shown more effective drug compounds in lab studies, leading to potential new treatments for inflammatory diseases.

Frequently asked questions

Does Dr. Erb study pain management for children?
Yes, Dr. Erb focuses on how to optimize opioid prescribing practices for pediatric patients recovering from surgeries.
What types of surgeries does Dr. Erb research?
He researches total knee replacements and methods for repairing Achilles tendon injuries.
Is Dr. Erb's work relevant to patients with inflammatory diseases?
Absolutely, his studies on drug development aim to create more effective treatments for conditions like rheumatoid arthritis.
How can Dr. Erb's research help post-surgery patients?
His research identifies predictors of recovery and suggests guidelines for better pain management and surgical outcomes.
What is the impact of Dr. Erb's drug research?
His work on p38 MAP kinase inhibitors aims to provide better anti-inflammatory medications that improve patients' quality of life.

Publications in plain English

The influence of guidelines on opioid prescribing practices after pe-diatric anterior cruciate ligament reconstruction.

2024

Journal of opioid management

Hudson T, Berkay F, Minhas A, Huff S, Henningsen J +3 more

Plain English
This study looked at how the introduction of new guidelines changed the way doctors prescribe opioids to children after they have knee surgery. It included 86 pediatric patients, and the findings showed that, after the guidelines were put in place, the average amount of opioids prescribed dropped significantly—by more than 20 units for each year of age. However, there was also an increase in the number of follow-up prescriptions given, meaning that while initial doses were lower, more patients needed extra medication later. Who this helps: This benefits pediatric patients recovering from surgery who need pain management.

PubMed

Preoperative Emergency Department Visits Are Predictive of 90-Day Postoperative Emergency Department Visits and Discharge Disposition in Total Knee Arthroplasty Patients.

2022

The journal of knee surgery

Kiskaddon EM, Soehnlen NT, Erb E, Froehle AW, Green U +1 more

Plain English
This study looked at whether visits to the emergency department (ED) before total knee surgery could predict if patients would need to return to the ED within 90 days after their surgery. Researchers analyzed data from 611 patients and found that those who had one or more ED visits before surgery were more likely to return to the ED afterward, especially if they had diabetes. Understanding this relationship helps doctors identify patients who may need extra care after surgery to improve their recovery and reduce post-operative complications. Who this helps: This benefits patients undergoing total knee replacements and their healthcare providers.

PubMed

Biomechanical Comparison of Tape Versus Suture in Simulated Achilles Tendon Midsubstance Rupture.

2021

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons

Meeks BD, Kiskaddon EM, Erb E, Gould G, Froehle A +1 more

Plain English
This study compared two methods of repairing torn Achilles tendons: using tape and using traditional sutures. Researchers found that the tape repair could handle more force before failing, with an average strength of 290.4 Newtons compared to 231.7 Newtons for sutures. This matters because stronger repairs may lead to better recovery outcomes for patients with Achilles tendon injuries. Who this helps: Patients with Achilles tendon injuries.

PubMed

KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.

2010

European journal of pharmacology

Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R +15 more

Plain English
This study focused on a new drug called KR-003048 that blocks a specific protein (p38 MAP kinase) linked to inflammation and diseases like rheumatoid arthritis. Researchers found that KR-003048 effectively reduced harmful inflammation in lab tests and in animal models, showing significant effects at doses of 10 and 30 mg/kg, which led to a decrease in joint swelling and damage related to arthritis. This new treatment could provide a way to manage chronic inflammatory conditions better and improve the quality of life for those affected. Who this helps: Patients suffering from inflammatory diseases like rheumatoid arthritis.

PubMed

Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site.

2010

Bioorganic & medicinal chemistry letters

Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R +18 more

Plain English
This study focused on improving a new type of drug designed to inhibit p38 MAP kinase, which is involved in inflammation. Researchers made changes to the drug’s structure, leading to candidates that showed promising results in lab tests and animal studies. One of these improved drugs has moved into phase II clinical trials to treat inflammatory conditions. Who this helps: This helps patients suffering from inflammatory diseases.

PubMed

The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitors.

2008

Bioorganic & medicinal chemistry letters

Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R +15 more

Plain English
Researchers developed new drugs that target a specific enzyme involved in inflammation. They created a series of compounds that not only attach to the main site of the enzyme but also bind to another important region, enhancing their effectiveness. Testing showed these compounds have properties suitable for creating an oral treatment, which is important for managing inflammatory diseases. Who this helps: This helps patients with inflammatory conditions.

PubMed

'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitors.

2008

Bioorganic & medicinal chemistry letters

Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R +14 more

Plain English
This research focused on creating new drugs that block a specific enzyme called p38, which plays a role in inflammation and disease. The scientists developed a new type of compound that is more effective than previous versions, showing improved performance in tests. This is important because better p38 inhibitors could lead to more effective treatments for conditions related to inflammation. Who this helps: This helps patients suffering from inflammatory diseases.

PubMed

Dental and mandibular injury in an Antarctic fur seal, Arctocephalus gazella, at Heard Island, Southern Ocean.

1996

Journal of wildlife diseases

Erb E, Shaughnessy PD, Norman RJ

Plain English
This study looked at the injuries of an Antarctic fur seal found on Heard Island, specifically focusing on its skull. Researchers found that the seal had a fractured left lower tooth, dislocated bones in its jaw, and infections affecting both sides of its jaw. These findings highlight the serious impact of injuries on the health of marine mammals. Who this helps: This information is useful for wildlife veterinarians and conservationists working to protect marine animals.

PubMed

Recursive deconvolution of combinatorial chemical libraries.

1994

Proceedings of the National Academy of Sciences of the United States of America

Erb E, Janda KD, Brenner S

Plain English
This study focused on developing a new method to identify which chemical compounds in a large collection—specifically a library of 1,024 peptides—can effectively bind to a particular antibody linked to beta-endorphin, a substance involved in pain relief and feelings of well-being. The researchers found that one peptide, as well as two other compounds, showed significant binding to the antibody, which is important for understanding how these peptides may be used in therapies related to pain management. This new method simplifies the process of identifying effective compounds without needing additional tags or complex techniques. Who this helps: This benefits researchers and pharmaceutical developers looking for effective treatments for pain and related conditions.

PubMed

Effect of propranolol on fetal tachycardia in diabetic pregnancy.

1978

The American journal of cardiology

Teuscher A, Bossi E, Imhof P, Erb E, Stocker FP +1 more

Plain English
This study examined the effect of the drug propranolol on controlling high heart rates in unborn babies of diabetic mothers. By giving a daily dose of 160 mg to a pregnant woman, the researchers were able to lower the baby’s heart rate from about 200 beats per minute to between 120 and 160 beats per minute. After birth, the baby’s blood showed propranolol levels that were higher than expected, but the treatment did not cause any negative side effects. Who this helps: This helps pregnant women with diabetes and their babies by safely managing fetal heart issues.

PubMed

Improving speech in Parkinson's disease.

1973

The American journal of nursing

Erb E

PubMed

[Prevention of pregnancy and pregnancy interruption. I].

1972

Zeitschrift fur Krankenpflege. Revue suisse des infirmieres

Erb E

PubMed

[Cancer of the pancreas].

1970

Therapeutische Umschau. Revue therapeutique

Erb E, Ferrero PM

PubMed

[On dislocations of the elbow joint].

1969

Therapeutische Umschau. Revue therapeutique

Erb E, Fehr AM

PubMed

Frequent Co-Authors

Antonio Garrido Montalban Erik Boman Chau-Dung Chang Susana Conde Ceide Russell Dahl David Dalesandro Nancy G J Delaet Andrew Gibbs Linda Kessler Jan Lundström

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.